Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector.

[1]  L. Villarreal,et al.  Adeno-associated virus vectors can be efficiently produced without helper virus , 1998, Gene Therapy.

[2]  E. Shillitoe.  Gene therapy for oral cancer: recent progress in research. , 1998, Oral oncology.

[3]  M. Mizuno,et al.  Adeno‐associated Virus Vector Containing the Herpes Simplex Virus Thymidine Kinase Gene Causes Complete Regression of Intracerebrally Implanted Human Gliomas in Mice, in Conjunction with Ganciclovir Administration , 1998, Japanese journal of cancer research : Gann.

[4]  C. Su,et al.  The relapse patterns and outcome of postoperative recurrent tongue cancer. , 1997, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  M. Mizuno,et al.  Gene therapy against an experimental glioma using adeno-associated virus vectors. , 1996, Gene therapy.

[6]  B. O’Malley,et al.  Combination gene therapy for oral cancer in a murine model. , 1996, Cancer research.

[7]  G. Clayman.  Gene therapy for head and neck cancer , 1995, Head & neck.

[8]  S. Meylaerts,et al.  Bystander tumoricidal effect in the treatment of experimental brain tumors. , 1994, Neurosurgery.

[9]  T. Shawker,et al.  The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. , 1994, Journal of neurosurgery.

[10]  J. Roth,et al.  Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. , 1994, Cancer research.

[11]  R. Kotin.  Prospects for the use of adeno-associated virus as a vector for human gene therapy. , 1994, Human gene therapy.

[12]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Gage,et al.  Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. F. Anderson.  Gene therapy for cancer. , 1994, Human gene therapy.

[15]  R. Warnick,et al.  In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. , 1993, Human gene therapy.

[16]  S. Freeman,et al.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. , 1993, Cancer research.

[17]  Z. Ram,et al.  In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. , 1993, Cancer research.

[18]  Z. Ram,et al.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.

[19]  K. Berns,et al.  Adeno-associated viruses: an update. , 1987, Advances in virus research.